↓ Skip to main content

Dove Medical Press

Article Metrics

Randomized Phase III evaluation of the efficacy and safety of a novel glycopyrrolate oral solution for the management of chronic severe drooling in children with cerebral palsy or other neurologic…

Overview of attention for article published in Therapeutics and Clinical Risk Management, January 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news
1 news outlet
policy
1 policy source

Citations

dimensions_citation
28 Dimensions

Readers on

mendeley
44 Mendeley
Title
Randomized Phase III evaluation of the efficacy and safety of a novel glycopyrrolate oral solution for the management of chronic severe drooling in children with cerebral palsy or other neurologic conditions
Published in
Therapeutics and Clinical Risk Management, January 2012
DOI 10.2147/tcrm.s26893
Pubmed ID
Authors

Robert Zeller, Lee, Cavanaugh, Davidson

Mendeley readers

The data shown below were compiled from readership statistics for 44 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 5%
Unknown 42 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 10 23%
Student > Master 6 14%
Student > Doctoral Student 6 14%
Other 5 11%
Student > Bachelor 4 9%
Other 11 25%
Unknown 2 5%
Readers by discipline Count As %
Medicine and Dentistry 24 55%
Agricultural and Biological Sciences 4 9%
Nursing and Health Professions 3 7%
Arts and Humanities 2 5%
Pharmacology, Toxicology and Pharmaceutical Science 2 5%
Other 3 7%
Unknown 6 14%

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 February 2017.
All research outputs
#2,161,389
of 17,361,274 outputs
Outputs from Therapeutics and Clinical Risk Management
#96
of 1,100 outputs
Outputs of similar age
#43,250
of 271,271 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#3
of 52 outputs
Altmetric has tracked 17,361,274 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,100 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.9. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 271,271 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 52 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.